Publications by authors named "Pablo Olivera"

Claim this Profile
I
Isolated Anastomotic Ulcers Are Associated with a Higher Long-Term Risk for Postoperative Recurrence and a Differential Mucosa-Associated Microbiome Composition in Patients with Crohn's Disease Following Ileocolic Resection.
Michiel Thomas Jan Bak, Pablo Andres Olivera, Cristian Hernandez-Rocha, Krzysztof Borowski, Williams Turpin

Inflamm Bowel Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world clinical characteristics and therapeutic strategies in patients with moderate-to-severe inflammatory bowel disease in Argentina: Data from the RISE-AR study.
Pablo Andres Olivera, Domingo Balderramo, Juan Sebastian Lasa, Ignacio Zubiaurre, Gustavo Correa

Gastroenterol Hepatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term comparative outcomes after ileocecal resection for inflammatory versus complicated Crohn's disease. A multicenter, retrospective study (Crohn's-Urg).
Nicolas Avellaneda, Annalisa Maroli, Gianluca Pellino, Michele Carvello, Anders Tottrup, Pablo A Olivera

Dig Liver Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International consensus on the use of intestinal ultrasound in inflammatory bowel disease trials.
Mariangela Allocca, Vipul Jairath, Bruce E Sands, David T Rubin, Bénédicte Caron, Pablo A Olivera

J Crohns Colitis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biobetters and biosimilars in inflammatory bowel disease.
Jacopo Fanizza, Ilaria Faggiani, Mariangela Allocca, Federica Furfaro, Alessandra Zilli, Pablo Andres Olivera

Best Pract Res Clin Gastroenterol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Micronutrients are associated with endoscopic postoperative recurrence in Crohn's disease: a multicenter prospective cohort study in North america.
Michiel T J Bak, Karen Boland, Shadi Nayeri, Krzysztof Borowksi, Pablo A Olivera

J Crohns Colitis· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International Magnetic Resonance Imaging Consensus for use in Luminal Crohn's Disease Trials and Clinical Practice.
Bénédicte Caron, Vipul Jairath, Bruce E Sands, David T Rubin, Mariangela Allocca, Pablo A Olivera

Clin Gastroenterol Hepatol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute Severe Ulcerative Colitis: An International Delphi Consensus on Clinical Trial Design and Endpoints.
Sailish Honap, Vipul Jairath, Bruce E Sands, Parambir S Dulai, Peter D R Higgins, Pablo A Olivera

Clin Gastroenterol Hepatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply.
Pablo A Olivera, Sun-Ho Lee, Kenneth Croitoru

Gastroenterology· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Life Exposure to Parental Crohn's Disease Is Associated With Offspring's Gut Microbiome, Gut Permeability, and Increased Risk of Future Crohn's Disease.
Sun-Ho Lee, Maham Bushra, Lanhui Qiu, Anne M Griffiths, Williams Turpin, Pablo A Olivera

Gastroenterology· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthy First-Degree Relatives From Multiplex Families vs Simplex Families Have Higher Subclinical Intestinal Inflammation, a Distinct Fecal Microbial Signature, and Harbor a Higher Risk of Developing Crohn's Disease.
Pablo A Olivera, Helena Martinez-Lozano, Haim Leibovitzh, Mingyue Xue, Anna Neustaeter

Gastroenterology· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Improvement in Health-Related Quality of Life With Advanced Therapies for Moderate-to-Severe Crohn's Disease: A Network Meta-Analysis.
Pablo A Olivera, María L Parks, Ignacio Zubiaurre, Laurent Peyrin-Biroulet, Juan S Lasa

Am J Gastroenterol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endoscopically Active Ulcerative Colitis Is Associated With Asymptomatic Atherosclerotic Vascular Disease: A Case-Control Study.
Juan Lasa, Ezequiel Nazario, Gonzalo De Sanctis, María Fernández Recalde, Juan Pereira Redondo, Pablo A Olivera

Inflamm Bowel Dis· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and prevalence of inflammatory bowel diseases in a population from Buenos Aires, Argentina.
Pablo Andrés Olivera, María Laura Parks, Deborah Pellegrini, Bárbara Finn, Ramiro Gutierrez

Gastroenterol Hepatol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preventing and managing cardiovascular events in patients with inflammatory bowel diseases treated with small-molecule drugs, an international Delphi consensus.
Pablo A Olivera, Axel Dignass, Marla C Dubinsky, Giovanni Peretto, Paulo G Kotze

Dig Liver Dis· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-term outcomes of surgical treatment for primary ileocaecal Crohn's disease: Results of the Crohn's(urg) study, a multicentre, retrospective, comparative analysis between inflammatory and complicated phenotypes.
Nicolas Avellaneda, Gianluca Pellino, Annalisa Maroli, Anders Tottrup, Gabriele Bislenghi, Pablo A Olivera

Colorectal Dis· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endoscopic scoring system utilization for inflammatory bowel disease activity assessment: A multicenter real-world study from Argentina.
Juan Lasa, Astrid Smolarczuk, Sofía Navar, Carla Ponce, Martín Galvarini, Pablo Olivera

Gastroenterol Hepatol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of regulatory guidance for JAK inhibitors use in patients with immune-mediated inflammatory diseases: An international appropriateness study.
Virginia Solitano, Paola Facheris, Magnus Petersen, Ferdinando D'Amico, Michela Ortoncelli, Pablo A Olivera

Autoimmun Rev· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges in the diagnosis and treatment of inflammatory bowel disease in Latin America.
Domingo Balderramo, Abel Botelho Quaresma, Pablo A Olivera, Mariane Christina Savio, Maria Paz Gimenez Villamil

Lancet Gastroenterol Hepatol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers That Predict Crohn's Disease Outcomes.
Pablo A Olivera, Mark S Silverberg

J Can Assoc Gastroenterol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significance of HLA-B[*]51 allele expression in Crohn's disease: a case-control study.
Alex Kostianovsky, Pablo E Llanquimán, Pablo A Olivera, Sebastián A Muñoz, Ignacio Gandino

Clin Exp Rheumatol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical Management of Biosimilar Use in Inflammatory Bowel Disease (IBD): A Global Survey and an International Delphi Consensus.
Ferdinando D'Amico, Virginia Solitano, Fernando Magro, Pablo A Olivera, Jonas Halfvarson

J Clin Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential Effects of Integrin Blockade on Gut and Sacroiliac Joint Inflammation.
Zoya Qaiyum, Michael Tang, Pablo Andres Olivera, Robert Davies Inman

J Rheumatol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
var. , a Crown Rust Pathogen of Two Highly Invasive Species, Is Detected Across the Midwest and Northeastern United States.
Nicholas Greatens, Nick Klejeski, Les J Szabo, Yue Jin, Pablo D Olivera

Plant Dis· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Review article: Risk of cardiovascular events in patients with inflammatory bowel disease receiving small molecule drugs.
Pablo A Olivera, Juan S Lasa, Giovanni Peretto, Stephane Zuily, Silvio Danese

Aliment Pharmacol Ther· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis